A review of current applications of mass spectrometry for neuroproteomics in epilepsy
- PMID: 19598206
- DOI: 10.1002/mas.20243
A review of current applications of mass spectrometry for neuroproteomics in epilepsy
Abstract
The brain is unquestionably the most fascinating organ, and the hippocampus is crucial in memory storage and retrieval and plays an important role in stress response. In temporal lobe epilepsy (TLE), the seizure origin typically involves the hippocampal formation. Despite tremendous progress, current knowledge falls short of being able to explain its function. An emerging approach toward an improved understanding of the complex molecular mechanisms that underlie functions of the brain and hippocampus is neuroproteomics. Mass spectrometry has been widely used to analyze biological samples, and has evolved into an indispensable tool for proteomics research. In this review, we present a general overview of the application of mass spectrometry in proteomics, summarize neuroproteomics and systems biology-based discovery of protein biomarkers for epilepsy, discuss the methodology needed to explore the epileptic hippocampus proteome, and also focus on applications of ingenuity pathway analysis (IPA) in disease research. This neuroproteomics survey presents a framework for large-scale protein research in epilepsy that can be applied for immediate epileptic biomarker discovery and the far-reaching systems biology understanding of the protein regulatory networks. Ultimately, knowledge attained through neuroproteomics could lead to clinical diagnostics and therapeutics to lessen the burden of epilepsy on society.
Copyright 2009 Wiley Periodicals, Inc.
Similar articles
-
Neuroproteomics in neurotrauma.Mass Spectrom Rev. 2006 May-Jun;25(3):380-408. doi: 10.1002/mas.20073. Mass Spectrom Rev. 2006. PMID: 16498609 Review.
-
Neuroproteomics - the tasks lying ahead.Electrophoresis. 2006 Jul;27(13):2819-29. doi: 10.1002/elps.200500892. Electrophoresis. 2006. PMID: 16739225 Review.
-
Current trends in computational inference from mass spectrometry-based proteomics.Brief Bioinform. 2007 Sep;8(5):304-17. doi: 10.1093/bib/bbm023. Epub 2007 Jun 20. Brief Bioinform. 2007. PMID: 17584764 Review.
-
Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.J Mass Spectrom. 2008 May;43(5):559-71. doi: 10.1002/jms.1409. J Mass Spectrom. 2008. PMID: 18416436 Review.
-
Comparative proteomics and correlated signaling network of rat hippocampus in the pilocarpine model of temporal lobe epilepsy.Proteomics. 2008 Feb;8(3):582-603. doi: 10.1002/pmic.200700514. Proteomics. 2008. PMID: 18186018
Cited by
-
Hippocampal Proteome of Rats Subjected to the Li-Pilocarpine Epilepsy Model and the Effect of Carisbamate Treatment.Pharmaceuticals (Basel). 2017 Jul 30;10(3):67. doi: 10.3390/ph10030067. Pharmaceuticals (Basel). 2017. PMID: 28758946 Free PMC article.
-
Mass Spectrometry as a Quantitative Proteomic Analysis Tool for the Search for Temporal Lobe Epilepsy Biomarkers: A Systematic Review.Int J Mol Sci. 2023 Jul 5;24(13):11130. doi: 10.3390/ijms241311130. Int J Mol Sci. 2023. PMID: 37446307 Free PMC article.
-
Proteomic analysis of human epileptic neocortex predicts vascular and glial changes in epileptic regions.PLoS One. 2018 Apr 10;13(4):e0195639. doi: 10.1371/journal.pone.0195639. eCollection 2018. PLoS One. 2018. PMID: 29634780 Free PMC article.
-
Serum Prolidase Enzyme Activity Level: Not a Predictive Biomarker for Epilepsy.Eurasian J Med. 2019 Feb;51(1):27-30. doi: 10.5152/eurasianjmed.2018.18183. Epub 2018 Nov 30. Eurasian J Med. 2019. PMID: 30911252 Free PMC article.
-
Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor.Int J Oncol. 2020 Feb;56(2):568-580. doi: 10.3892/ijo.2019.4948. Epub 2019 Dec 20. Int J Oncol. 2020. PMID: 31894270 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical